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ECM deposition is driven by caveolin-1–dependent
regulation of exosomal biogenesis and cargo sorting
Lucas Albacete-Albacete1, Inmaculada Navarro-Lérida1, Juan Antonio López2,3, Inés Mart́ın-Padura1, Alma M. Astudillo4,5, Alessia Ferrarini2,
Michael Van-Der-Heyden6, Jesús Balsinde4,5, Gertraud Orend6, Jesús Vázquez2,3, and Miguel Ángel del Pozo1
The composition and physical properties of the extracellular matrix (ECM) critically influence tumor progression, but the
molecular mechanisms underlying ECM layering are poorly understood. Tumor–stroma interaction critically depends on cell
communication mediated by exosomes, small vesicles generated within multivesicular bodies (MVBs). We show that
caveolin-1 (Cav1) centrally regulates exosome biogenesis and exosomal protein cargo sorting through the control of
cholesterol content at the endosomal compartment/MVBs. Quantitative proteomics profiling revealed that Cav1 is required for
exosomal sorting of ECM protein cargo subsets, including Tenascin-C (TnC), and for fibroblast-derived exosomes to
efficiently deposit ECM and promote tumor invasion. Cav1-driven exosomal ECM deposition not only promotes local stromal
remodeling but also the generation of distant ECM-enriched stromal niches in vivo. Cav1 acts as a cholesterol rheostat in MVBs,
determining sorting of ECM components into specific exosome pools and thus ECM deposition. This supports a model by
which Cav1 is a central regulatory hub for tumor–stroma interactions through a novel exosome-dependent ECM deposition
mechanism.
Introduction
The tumor microenvironment is a key factor in multiple stages
of disease progression, including local invasion and distant
metastasis (Chen et al., 2015; Quail and Joyce, 2013; Quail et al.,
2013). Cancer-associated fibroblasts (CAFs) are an important cell
subpopulation and constitute a major source of paracrine growth
factors and ECM components (Augsten et al., 2014; Kalluri, 2016).
However, the molecular mechanisms driving ECM deposition
are incompletely understood. Recent studies confirm that ECM
deposition ultimately depends on a functional core secretion
machinery (Unlu et al., 2014), but further mechanistic charac-
terization is warranted.
Exosomes are vesicles secreted by most cell types, generated
from intraluminal vesicles (ILVs) of multivesicular bodies
(MVBs), membrane-bound compartments linked to the endo-
somal system (Colombo et al., 2014; Gruenberg and Maxfield,
1995; van Niel et al., 2006). Exosomes enable a given cell to
modulate the behavior of other cell populations through the
transfer of effector or regulatory molecules, often over long
(interorgan) distances (Braicu et al., 2015; Raposo and Stoorvogel,
2013), and can mediate tumor–stroma communication and pre-
metastatic niche formation (Costa-Silva et al., 2015; Hoshino et al.,
2015; Peinado et al., 2012).
Exosomal cargo composition is complex, containing proteins,
small ligand peptides, and regulatory nucleic acids (Colombo
et al., 2014), but its regulation is poorly understood. Endo-
somal sorting complexes required for transport (ESCRT)
machinery–dependent and ESCRT-independent mechanisms
coexist (Babst, 2011; Villarroya-Beltri et al., 2014), reflecting the
heterogeneity of MVBs and exosomes and their potential dif-
ferential impact on health and disease. Exosome biogenesis is
also modulated by the organization of membrane subdomains
through lipid composition of MVB membranes (Record et al.,
2018). Cholesterol is likely relevant, given its higher abundance
at MVBs compared with other compartments (Möbius et al.,
2003) and its involvement in the formation of high-curvature
membrane structures such as caveolae and synaptic vesicles.
Cholesterol, long-chain sphingolipids, and phosphatidylserine
(PS) 18:0/18:1 are also significantly enriched in exosome
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Enfermedades Cardiovasculares, Madrid, Spain; 4Instituto de Bioloǵıa y Genética Molecular, Consejo Superior de Investigaciones Cient́ıficas, Universidad de Valladolid,
Valladolid, Spain; 5Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain; 6Institut
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membranes (Skotland et al., 2019; Wang et al., 2007; Wubbolts
et al., 2003). ER-endosome/MVB contacts allow for the regu-
lated transfer of proteins and lipids, especially cholesterol, and
are modulated through specific protein tethers, especially
members of the oxysterol-binding protein (ORP) family (ORP1L
and ORP5). Cholesterol accumulation decreases ER-MVB con-
tacts (Raiborg et al., 2015; Rocha et al., 2009). Still, we lack a
complete picture of the mechanisms modulating cholesterol
levels at MVBs and their impact on exosome biology.
Endomembrane trafficking is regulated by caveolin-1 (Cav1),
an essential scaffolding component of invaginated plasma-
lemmal nanodomains (caveolae). Cav1 participates in several
essential cell functions, including mechanoadaption, endocyto-
sis, spatiotemporal control of signal transduction, cholesterol
homeostasis (Parton and del Pozo, 2013; Pol et al., 2020), and
interorganelle communication, being an integral component of
mitochondria-associated ER membranes, a membrane contact
site (MCS) of specialized ER regions and mitochondria (Sala-Vila
et al., 2016). Cav1 plays multiple, yet context-dependent, roles in
tumor biology and is required for ECM biomechanical remod-
eling by CAFs promoting tumor invasion and metastasis (Goetz
et al., 2011). Exosomal secretion of Cav1 occurs (Logozzi et al.,
2009), but its relevance for Cav1-dependent stromal remodeling
is unknown.
Here, we demonstrate that Cav1 is a constitutive component
of exosomes produced by several cell types, including primary
CAFs. N-terminal ubiquitin acceptor lysines are essential for
Cav1 sorting into the MVB compartment. Comparative proteo-
mics and lipidomics revealed that Cav1 modulates exosome
cargo sorting and segregation of exosome subpopulations
through a cholesterol-dependent mechanism to enable in-
corporation of ECM components, including Tenascin-C (TnC),
an important driver of tumor progression, and exosome se-
cretion is strictly required for their deposition. Exosomes
derived from Cav1 knockout (KO) fibroblasts failed to deposit
ECM and promote tumor cell invasiveness. Cav1-dependent
remote exosomal ECM deposition occurs in vivo, suggesting
the relevance of stromal Cav1 for distant ECM niche nuclea-
tion. We propose that Cav1 is a key regulatory hub also fos-
tering stromal environments through the modulation of MVB
membrane plasticity and exosome cargo specification, which
depend on cholesterol content and organization.
Results
Cav1 redistributes to late endosome (LE)/MVB to its sorting
in exosomes
Cav1 internalization is tightly regulated (del Pozo et al., 2005;
Nabi and Le, 2003; Zimnicka et al., 2016). Although endocytosed
Cav1 has commonly been regarded as committed to degradation
(Botos et al., 2008; Hayer et al., 2010), alternative fates cannot be
excluded (Mundy et al., 2012). We analyzed the trafficking dy-
namics of endogenous Cav1 upon treatment with sodium or-
thovanadate, which induces Cav1 internalization by protecting
Cav1 phosphorylation at tyrosine 14 (del Pozo et al., 2005). Or-
thovanadate exposure increased Cav1 phosphorylation and co-
localization with LEs and MVBs (anti–lyso-bis-phosphatidic acid
[LBPA] and anti-CD63 immunostainings, respectively; Fig. 1 A
and Fig. S1 A). Similarly, a significant fraction of Cav1 relocalized
to the LE/MVB compartment upon exposure of cells to EDTA,
which induces Cav1 endocytosis by promoting cell detachment
(Fig. S1 B; Grande-Garćıa and del Pozo, 2008). RNAi-mediated
depletion of polymerase I and transcript release factor (PTRF/
Cavin-1), an essential caveolar coat component required for
caveolae stabilization (Hill et al., 2008), also induced partial Cav1
relocalization—albeit below significance threshold—and in-
creased Cav1 phosphorylation (Fig. S1 C). High-resolution mi-
croscopy confirmed the constitutive presence of Cav1 in the
MVB lumen, colocalizing with the exosomal marker CD63 (Fig. 1
B). Discrete patches of Cav1 localizing to ILVs within MVBs were
clearly observable by artificially enlarging endosomes (Fig. 1 C
and Fig. S1 D; Trajkovic et al., 2008). These observations dem-
onstrate that MVBs are one of the destinies of endocytosed Cav1.
Phosphorylation often triggers subsequent ubiquitination of
adjacent acceptor residues (Hunter, 2007). We analyzed the
subcellular distribution of Cav1 mutants in which ubiquitin ac-
ceptor lysine residues are replaced by arginine (Fig. 1 D, upper
panel). Mutation of Cav1 N-terminal lysines impairs Cav1
ubiquitination (Kirchner et al., 2013). Cav1 constructs nicely
decorated the outer enlarged-Rab5 endosome membrane/MVB;
however, mutation of the N-terminal lysine cluster (K5-57R and
K5-176R mutants) abolished Cav1 sorting into ILVs (Fig. 1 D),
correlating with lower overall colocalization of these mutants
with CD63 (Fig. S1 E). In contrast, mutation of C-terminal lysine
residues (K65-176R) did not affect the ability of Cav1 to localize
inMVBs (Fig. 1 D). Phosphorylation was not significantly altered
in Cav1 mutants (Fig. 1 E), reinforcing the notion of a two-step
mechanism for Cav1 sorting into MVBs: phosphorylation first
elicits Cav1 internalization toward the outer MVB membrane,
and ubiquitination acts as a checkpoint for Cav1 sorting
into ILVs.
To assess the exosomal sorting of the ILV-localized Cav1 pool,
we analyzed density gradient–purified exosomes from different
cell lines. Endogenous Cav1 mainly partitioned with Tsg101,
confirming that exosomes can carry Cav1 (Fig. 1 F). Cav1 sorting
to exosomes was enhanced in PTRF-depleted mouse embryonic
fibroblasts (MEFs; Fig. S1 F). In contrast, N-terminal ubiquiti-
nation mutants exhibited impaired exosomal sorting (Fig. 1 G).
These data suggest that a significant proportion of internalized
Cav1 is sorted to the MVB lumen in a ubiquitin-dependent
manner, favoring its incorporation into exosomes. This pro-
cess is constitutive in all Cav1-expressing cell lines tested.
Cav1 regulates exosomal biogenesis through modulation of
MVB cholesterol content
The regulated composition and organization ofMVBmembranes
yield different ILV and exosome populations (Colombo et al.,
2014). We explored whether Cav1, a regulator of endomem-
brane compartments (Pol et al., 2020), plays an active role in
exosome biogenesis. Cav1KO fibroblasts were not impaired for
exosome biogenesis and displayed higher rates of exosome se-
cretion, as determined by Western blot of total purified exo-
somes from equal cell numbers (Fig. 2, A and B, upper panel in
A), sucrose density gradient sedimentation (Fig. 2 A, lower
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Figure 1. Internalized Cav1 is sorted to exosomes. (A) Confocal images of Cav1 (red) and LBPA (green) in WT MEFs after treatment with sodium or-
thovanadate (NaV; 2 h). White arrows: plasma membrane–localized Cav1. Gray arrows: Cav1 relocalized to perinuclear area (scale bar, 25 µm). Charts show
Albacete-Albacete et al. Journal of Cell Biology 3 of 23
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panel; and Fig. 3 D), and physical characterization (Nanosight
technology, transmission EM [TEM]; Fig. 2, C andD; Dragovic et al.,
2011). We identified two exosome subpopulations of different sizes
in WT fibroblasts, whereas Cav1KO fibroblasts produced a homo-
geneous population of small exosomes (Fig. 2, C and D).
Cav1 binds cholesterol and organizes specialized membrane
organization domains (Murata et al., 1995; Pol et al., 2020). We
studied whether Cav1 promotes exosome heterogeneity by
modulating cholesterol levels at MVBs. While the number of
LBPA-positive structures did not differ betweenWT and Cav1KO
fibroblasts, MVB area and filipin intensity (a proxy for mean
cholesterol content) were significantly higher in Cav1KO cells
(Fig. 2 E). This phenotype was recapitulated by siRNA depletion
of Cav1 in WT cells (Fig. S2 A). Treatment with U18666A, which
promotes cholesterol accumulation in the LE/MVB compartment
(Cenedella, 2009), also increased exosome secretion while re-
ducing exosome heterogeneity in WT cells (Fig. 2 F).
A major share of MVB cholesterol is contained in ILVs
(Möbius et al., 2003). We confirmed this cholesterol accumu-
lation in enlarged endosomes by overexpressing constitutively
active Rab5(Q79L) (Fig. S2 B). To confirm whether altered cho-
lesterol content in Cav1KO MVBs induces exosome membrane
reorganization, we isolated cold-detergent–resistantmembranes
(exosome DRMs) from exosomes produced by either WT cells
(control or U18666A treated) or Cav1KO cells. Flotillin-1, a
marker for exosomes and liquid ordered domains, showed a
wider distribution in Cav1KO cells (fractions 1 to 8) or U18666A-
treated WT cells (fractions 1 to 6); in contrast, flotillin accu-
mulation in untreated WT cell–derived exosomes was restricted
to fractions 1 to 3 (Fig. 2 G), reflecting the increased highly or-
dered membrane content of Cav1KO-derived exosomes. Lip-
idomic analyses of exosome preparations confirmed a significant
enrichment in PS—in particular PS (18:0/18:1) species—in
agreement with previous data (Skotland et al., 2019). Of note,
exosomes derived from WT cells invariably exhibited higher
relative amounts of phosphatidic acid, phosphatidylinositol, and
LBPA (which is known to play a relevant role in ILV biogenesis
and dynamics; Cenedella, 2009; Kowal et al., 2014; Subra et al.,
2007) compared with Cav1KO exosomes, which conversely dis-
played an increased amount of cholesterol (Fig. S2 C), in
agreement with the observed accumulation of cholesterol at LE/
MVB compartments of Cav1KO cells. These results suggest that
Cav1 regulates exosome biogenesis by acting as a “cholesterol
rheostat” at LE/MVBs, conferring plasticity to this compartment
and enabling the segregation of different exosome populations.
Cav1 promotes the sorting of specific ECM cargoes
into exosomes
Wequantitated the proteomes ofWT and Cav1KO fibroblasts and
their corresponding exosome preparations. This analysis iden-
tified a subproteome that is equally abundant inWT and Cav1KO
whole-cell lysates, but whose components are differentially
sorted into exosomes depending on the Cav1 genotype (Fig. 3 A,
left). With a threshold of |Zq| > 1.5, in Cav1KO exosomes 152
proteins were more abundant and 163 less abundant than in WT
exosomes. Interaction network and functional annotation en-
richment analysis revealed that WT-derived exosomes were
significantly enriched in ECM components (including TnC, fi-
bronectin [FN], nidogen, emilin, EDIL3, and heparan sulfate
proteoglycans) and endosomal/endomembrane system compo-
nents (Fig. 3 A, right upper panel; Fig. 3 B; Fig. S2 D; and Data S1).
Conversely, a marked enrichment for DNA/RNA binding and
chaperone proteins such as histones in Cav1KO exosomes was
observed (Fig. 3 A, right lower panel; Fig. 3 B; Fig. S2 D; and Data
S1). Consistent with our data supporting increased cholesterol
content in Cav1KO MVBs, various annexin family members
were substantially enriched in Cav1KO exosomes, despite a de-
creased abundance of these proteins in Cav1KO whole-cell ly-
sates (Fig. 3 C). Annexins are Ca2+-dependent proteins that bind
cholesterol-rich membranes, providing lipid-clustering activity,
and may constitute a mechanism to accommodate cholesterol
excess in Cav1KO exosomes (Lizarbe et al., 2013).
Differential exosome sorting of selected proteins was vali-
dated by Western blot analysis of exosome fractions (Fig. S2 G
and Fig. S3 I) and iodixanol density gradients (Fig. 3 D). As
shown in Fig. 3 D, the distributions of exosome markers and
cargoes markedly correlated. A particular difference was ob-
served for TnC (Zq = 3.02), an ECM protein involved in devel-
opment, stem cell niche formation, and aggressive tumor
metastasis (Lowy and Oskarsson, 2015; Midwood et al., 2016;
Midwood and Orend, 2009). TnC was prominent in WT-derived
exosomes but virtually absent in Cav1KO exosomes (Data S1).
TnC colocalized with Cav1 within MVBs in fibroblasts and U251
cells (a TnC-secreting glioblastoma cell line; Fig. S2 E; Brösicke
et al., 2013). Knockdown (KD) of Cav1 across different tumor cell
lines (breast, glioblastoma, and melanoma) recapitulated the
Pearson´s correlation coefficient for Cav1-LBPA colocalization. Error bars: mean ± SD; n = 80 cells. Western blot: phospho-Cav1 (pCav1) and total Cav1 in
sodium orthovanadate–treated cells. (B) Cav1-CD63 colocalization. Right panels show high-resolution images of an MVB compartment (scale bar, 1 µm).
(C) Cav1 distribution in Rab5(Q79L)-expressing COS7 cells (scale bar, 10 µm). Right: zoomed view of an endosome (scale bar, 2.5 µm). (D) Top: cartoon of
assayed Cav1 constructs. Ubiquitination-target lysine residues (Ub) and residues mutated to arginine (X) are indicated. Bottom: confocal analysis of COS7 cells
transfected with Rab5(Q79L) (green) and indicated Cav1 constructs (scale bar, 10 µm). Chart: endosomal lumen localization of Cav1 variants (internal, INT;
white) versus the endosomal membrane (peripheral, MEMB; gray), expressed as percentage of total endosomal localization. Error bars are mean ± SD; n > 20
endosomes. (E) Western blot analysis of sodium orthovanadate–induced phosphorylation in WT Cav1 (pCav1), ubiquitination-target lysine mutants, and
nonphosphorylatable Y14F Cav1. (F) Cav1 inclusion in exosomes derived from fibroblasts (MEFs). RepresentativeWestern blots of exosomal proteins floated on
a continuous sucrose gradient (0.25–2 M). Individual 1-ml fractions were collected and after protein precipitation were loaded on electrophoresis gels and
analyzed for Cav1 and the exosome marker Tsg101. Red rectangles highlight fractions with detectable amounts of the exosome marker Tsg101 (3–7).
(G) Western blot analysis of cell lysates and exosomes of COS7 cells expressing HA-tagged Cav1 ubiquitination mutants. CNTRL, control; n.s., not significant.
For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 2. Cav1 regulates exosome biogenesis by modulating MVB cholesterol content. (A–G) Exosomes were isolated from supernatants of Cav1WT and
Cav1KO fibroblast cultures. (A) Top: Western blots for indicated proteins in exosomes derived from equal cell numbers. Bottom: Western blots showing the
Albacete-Albacete et al. Journal of Cell Biology 5 of 23
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phenotype of blunted TnC secretion observed in Cav1KO MEFs
(Fig. S2, H and I).
This supports that Cav1 modulates exosome biogenesis and
ECM cargo sorting across different cell types and is a prominent
regulator of exosome-mediated intercellular communication.
Exosome biogenesis/secretion modulates ECM deposition
We examinedwhether exosome-delivered ECM components can
initiate de novo ECM deposition. Cav1-deficient fibroblasts de-
posited less TnC fiber matrix than WT cells (Fig. 4 A). TnC fiber
deposition was also reduced in U18666A-treated cells (Fig. 4, B
and C; and Fig. S3 B). Reduced TnC deposition correlated with
intracellular TnC accumulation in Cav1-deficient cells; this effect
was less evident in U18666A-treated cells, probably reflecting a
higher TnC degradation rate (Fig. 4 B). TnC was less abundant in
exosomes derived from Cav1KO and Cav1KD MEFs or U18666A-
treated WT MEFs (Fig. 4 D and Fig. S2 F). We used two different
exosome secretion inhibitors to assess the contribution of exo-
somes to extracellular TnC fiber deposition: dimethylamiloride
(dmA; a H+/Na+ and Na+/Ca2+ channel inhibitor) and GW4869 (a
neutral sphingomyelinase [nSMase]-2 inhibitor; Savina et al.,
2003; Trajkovic et al., 2008). Net exosome release by WT fi-
broblasts was reduced by GW4869 and to a lesser extent by dmA
(Fig. S3 A), correlating with impaired TnC fiber deposition
(Fig. 4 E). Both treatments led to intracellular accumulation of
TnC aggregates (Fig. 4 E and Fig. S3 C). Deposition of FN, another
key ECM component underrepresented in Cav1KO exosomes
(Fig. 3 B, Fig. S3 I, and Data S1), was also reduced by exposure to
exosome secretion inhibitors, with GW4869 having a much
stronger effect (Fig. 4 F), although no significant differences
could be observed upon U18666A treatment (Fig. S3 K). Rele-
vance of exosome secretion for ECM deposition was also con-
firmed in primary CAFs, in which exosome release was largely
inhibited by GW4869, whereas dmA had virtually no effect (Fig.
S4 A). Accordingly, TnC and FN deposition was specifically af-
fected by nSMase2 blockade, whereas dmA had no effect (Fig. S4
B and Fig. 4 C). Neither GW4869 nor dmA affected ER-Golgi
homeostasis in MEFs or CAFs (Fig. S3 D, Fig. 3 E, Fig. S4 D,
and Fig. 4 E), ruling out compromised ER-Golgi secretory
function as a potential cause of defective deposition of ECM
components.
ESCRT machinery-regulated trafficking and ceramide bio-
genesis pathways generate exosomes with different cargoes
(Colombo et al., 2014). We analyzed the effect of transient KD
of either Tsg101 (a core regulator of the ESCRT-dependent
pathway) or nSMase1 and 2 (key regulators of ceramide me-
tabolism) on TnC matrix deposition (Fig. S3, F and G). Consis-
tent with small inhibitor experiments (Fig. 4 E), KD of either
pathway impaired TnC deposition, with ceramide synthesis
disruption yielding stronger effects (Fig. 4 G and Fig. S3 H).
These treatments also reduced FN deposition (Fig. S3 J). Thus,
exosomes are a general ECM deposition mechanism, and
ceramide-dependent exosome biogenesis is a major limiting
step in this process.
TnC incorporation into exosomes has an intracellular origin
and depends on cholesterol modulation
To rule out an external origin of exosome-incorporated TnC
through endocytic trafficking, we developed an assay based on
cell-derived matrices (CDMs). CDMs were generated by de-
cellularization of ECMs synthesized in vitro by WT or TnCKO
MEFs. We confirmed that TnCKO cells were specifically im-
paired for TnC deposition; other components, such as FN, did not
exhibit such dramatic dependence and showed a slight up-
regulation, likely because of the existence of alternative com-
pensatory routes (Fig. 5 A and Fig. S5 A; see also Fig. S3 I).
TnCKO or WT cells were then seeded on each of these CDMs
(Fig. 5 B), and TnC internalization was determined. No intra-
cellular TnC was detected inside TnCKO fibroblasts grown on
TnC-rich CDMs, thus excluding endocytosis as an active TnC
pool for exosome cargo sorting.
To exclude the possibility that TnC detected in purified
exosome fractions came from passive, nonspecific binding of
extant extracellular TnC fibers to secreted exosomes, purified
exosomes from TnCKO cells were incubated with TnC-rich
matrix produced by WT cells (Fig. 5 C and Materials and meth-
ods section). We failed to detect TnC protein in TnCKO exosomes
after their incubation with TnC-rich matrix (Fig. 5 C).
We then separated MVBs from the ER and Golgi compart-
ments (which fractionate together). In untreated WT cells, TnC
cosedimented both with MVB and ER markers (Fig. 5 D); how-
ever, upon treatment with GW4869, TnC was largely excluded
fromMVB fractions, a distribution shift recapitulated in Cav1KO
cells (Fig. 5 D). Accordingly, a major fraction of cellular TnC
colocalized with the ER in Cav1KO cells or GW4869-treated
WT cells (Fig. 5 E and Fig. S4 F). This colocalization was en-
hanced upon chloroquine supplementation (Fig. S4 F), suggest-
ing that defective transfer of TnC from the ER toMVBs results in
ER retention of TnC and subsequent targeting for lysosomal
degradation, supporting that lysosomal degradation enables TnC
distribution of Cav1 and Tsg101 in exosomes floated on a continuous sucrose gradient. (B)Quantification of exosome particles relative to cell number. Error bar
are means ± SD; n = 10. (C) Left: Nanosight distribution profiles of exosome preparations fromWT and Cav1KO fibroblasts, showing greater morphological and
size heterogeneity of WT-derived exosomes. Right: Quantification of the two exosome populations identified in WT and Cav1KO fibroblasts. Error bars are
mean ± SEM; n = 10. (D) Representative TEMs of WT and Cav1KO exosomes (scale bar, 200 nm). Distribution profiles measured from TEMs of WT and Cav1KO
fibroblast-derived exosomes. (E) Filipin staining (gray) and LBPA (green) of WT, Cav1KO, and U18666A-treated Cav1WT fibroblasts (scale bar, 20 µm). Lower
panel rows show zoomed views (scale bar, 6 µm). Charts on the right show quantitative analysis of filipin mean fluorescence intensity in MVBs (upper) and
total MVB area (lower). Error bar are means ± SD; n = 3. (F) Exosome production per cell. Error bars are means ± SD; n = 4 (left) and Nanosight distribution
profiles of exosome preparations (right) from WT fibroblasts without treatment (control) and treated with U18666A. (G) Western blots of sucrose density
gradient fractions in the presence of TritonX-100 of exosomes produced by untreated WT and Cav1KO fibroblasts and U18666A-treated WT fibroblasts. The
chart shows the proportion of flotillin (Flot1) in detergent-resistant and nonresistant membranes (DRM). Error bars are mean ± SD; n = 3. For all graphs, *, P <
0.05; **, P < 0.01; ***, P < 0.001.
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Figure 3. Cav1 specifies protein cargo into exosomes. (A) Representation of hierarchical analysis of proteins equally expressed in the two parental cell
populations (cell lysates, shaded in yellow) and differentially expressed in exosomes. Blue: proteins up-regulated inWT exosomes; red: proteins up-regulated in
Cav1KO exosomes. Graphics on the right show STRING network analysis. Top: interactions among identified proteins up-regulated in Cav1WT MEF-derived
exosomes. Highlighted groups are related to ECM components (blue) and extracellular vesicle/exosome biogenesis and lysosome components (green). Bottom:
interactions among identified proteins up-regulated in Cav1KO MEF-derived exosomes. Highlighted groups are related to histones (red) and DNA/RNA binding
Albacete-Albacete et al. Journal of Cell Biology 7 of 23
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removal when its exosome sorting fails. Degradation rate dif-
ferences could explain the variability in TnC accumulation in
Cav1KO cells and WT cells treated with exosome inhibitor drugs
and the lack of ER stress upon severe disruption of exosome
biogenesis and secretion.
Thus, the presence of TnC in exosomes reflects true regulated
intracellular sorting of TnC into MVBs, likely through a mech-
anism involving ER-MVB contact sites. This exosomal TnC pool
is sourced in the cell from de novo translation and not from
endocytosed material.
MCSs are small, specialized domains through which different
membrane compartments communicate, allowing the active
transfer of ions and lipids, including cholesterol in the case of
ER-endosomal MCSs (summarized in a graphical scheme in Fig.
S3 L; Rocha et al., 2009). We hypothesized that ER-MVB MCS
disruption alleviates cholesterol accumulation in Cav1KO cells
and restores the impaired sorting of ECM proteins onto exo-
somes. We knocked down ORP1L and vesicle-associated protein
A (VAPA), as these components of the ER-endosome tether
complex VAPA:ORP1L are relevant regulators of ER-to-endo-
some cholesterol transfer. Disruption of these contact sites in
Cav1KO cells significantly reduced LE/MVB size and filipin
staining intensity (Fig. 6 A and Fig. S5 D). Cholesterol content
reduction upon disruption of these contact sites correlated with
a rescue of TnC incorporation into MVBs (Fig. 6 B) and extra-
cellular TnC fiber deposition to levels comparable to those ob-
served in WT cells (Fig. 6 C).
To further characterize the role of endosomal cholesterol
accumulation in the sorting of ECM proteins onto exosomes, we
assessed the impact of loading WT cells with exogenous low-
density lipoprotein (LDL)-cholesterol on TnC trafficking into
LE/MVBs. Importantly, cholesterol-loaded cells showed a drastic
reduction in the accumulation at LE/MVBs and extracellular
deposition of TnC (Fig. S4, G and I).
Thus, the control of cholesterol content in the endosomal
compartment is a key mechanism regulating exosome biogene-
sis and exosomal cargo specification, of which Cav1 is a relevant
player.
Cav1-dependent exosome biogenesis directly drives ECM
deposition and subsequent increase in tumor cell invasiveness.
We compared the ability of exosomes purified from eitherWT or
Cav1KO MEFs to deposit TnC on 2D cultures of the noninvasive
breast cancer tumor cell line MDA-MB468, which naturally
expresses negligible levels of Cav1 and TnC (Kang et al., 2016).
After 24 h, tumor cells internalized prelabeled WT and Cav1KO
exosomes with similar efficiency, as shown by similar accu-
mulation of the general membrane dye PKH67 (Fig. 7 A, green).
However, only WT exosomes led to detectable deposition of TnC
in areas close to the periphery (Fig. 7 A, in red). In contrast,
MDA-MB468 cultures exposed to Cav1KO exosomes showed TnC
deposition levels comparable to those displayed by control cul-
tures (exposed to vehicle). Exosomes thus have an intrinsic
ability to deposit specific ECM material in vitro that requires
Cav1-dependent regulation of exosome biogenesis.
Cav1-dependent exosomal deposition of TnC induced im-
portant morphological changes in MDA-MB468 tumor cells,
eliciting cell-cell adhesion loss and internalization of the epi-
thelial marker E-cadherin, associated with increased protru-
siveness and emission of filopodia (Fig. 7 B). A similar phenotype
was observed when using CAF lines transduced with lentiviral
shRNA-encoding vectors (Fig. S5 C). Accordingly, MDA-MB468
cells exhibited increased migration, as assessed by wound
healing and transwell migration assays (Fig. S5, F and G). In-
terestingly, exosomes purified from MDA-MB231 tumor cells,
which contain low TnC compared with exosomes derived from
WT fibroblasts despite having comparable amounts of Cav1
protein, failed to up-regulate protrusiveness and motility of
MDA-MB468 cells (Fig. S5 B; Fig. S2, G and H; and Data S2).
Thus, exosomal TnC/ECM cargo derived from stromal fibro-
blasts, and not exosomal Cav1 per se, drives the induction of
invasive phenotypes in tumor cells.
We studied the ability of exosomes to deposit ECM on MDA-
MB468 spheroids, scaffold-free 3D assemblies in which cells
self-organize ECM and engage in intercellular communication
and which have been validated as superior in vitro experimental
proxies of live tissues for many applications (Fennema et al.,
2013; Zanoni et al., 2016). WT-derived TnC-containing exo-
somes, but not exosomes derived from Cav1KO or Cav1KD fi-
broblasts (i.e., TnC depleted), efficiently deposited fibrillar TnC
structures within cell spheroids (Fig. 7 C). 3D reconstruction
demonstrated that TnC fibrils were preferentially located in the
interstitial space (Fig. S5 E).
To characterize Cav1-dependent, exosome-induced pheno-
typic changes in tumor cells in this setting, spheroids generated
in the presence of exosomes were plated and cells were al-
lowed to migrate for 72 h. WT exosomes promoted signifi-
cantly more migration than exosomes derived from Cav1KO
MEFs (Fig. 7 D). To confirm the role of TnC in this process, we
tested the effect of exosomes derived from TnCKO MEFs
(Fig. 7 G and Fig. S5, H and I). TnCKO exosomes were poor
stimulators of cell migration, supporting that the observed
phenotypic impact derives largely from the sorting of specific
ECM cargoes to exosomes.
We next examined whether exosomes increased tumor cell
invasiveness. Cav1KO exosomes consistently exhibited a blunted
ability to induce invasiveness in Matrigel invasion assays (Fig. 7
E) or 3D collagen matrix invasion assays (Fig. 7 F), similar to the
reduced invasion promoted by exosomes derived from TnCKO
cells (Fig. 7 G). These results further support the relevance of
(orange). (B) Clustered heatmap of extracellular proteins with significant changes in ECM protein abundance between exosomes produced by WT and Cav1KO
fibroblasts (top) or in histone-related proteins (bottom). (C) Heatmap comparing annexin isoform enrichment in exosomes produced by Cav1KO and WT
fibroblasts. (D) Western blot analysis showing the distribution of Cav1 and some of the proteins identified by quantitative proteomics in WT and Cav1KO-
derived exosomes floated on an Optiprep (iodixanol) density gradient. Tsg101, Alix, and flotillin-1 were used as exosomal markers, and GM130 was included as a
negative control.
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Figure 4. Exosome-mediated ECM deposition is a Cav1-dependent process. (A) Z-stack projection of confocal images showing TnC (red) in matrix de-
posited by WT, Cav1KD, and Cav1KO MEFs. F-actin is shown in green (scale bar, 40 µm). Zoomed views reveal an absence of TnC matrix deposition and a
Albacete-Albacete et al. Journal of Cell Biology 9 of 23
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Cav1- and TnC-dependent exosome-induced ECM deposition
and phenotypic alteration for tumor progression.
Cav1WT MEF-derived exosomes create TnC-rich niches in vivo
To evaluate whether exosomes deposit TnC in vivo over large
(interorgan) distances, exosomes purified from WT or Cav1KO
fibroblasts were fluorescently labeled and injected into the
caudal vein of TnCKO mice every day for 1 wk (Fig. 8 A). His-
topathological analysis revealed specific exosome accumulation
in liver and, to a lesser extent, in lung (Fig. 8 B and Fig. S5 J).
However, associated TnC deposition was only consistently de-
tectable in liver and lung of mice injected with WT exosomes,
contrasting with the residual TnC staining in the organs of an-
imals injected with Cav1KO exosomes or vehicle (PBS), despite
Cav1KO exosomes being able to reach this organ with compa-
rable efficiency. Thus, Cav1 has a key role in exosome-dependent
ECM deposition in vivo. Because TnC is a positive regulator of
metastasis through the assembly of favorable distant micro-
environments, Cav1 might specifically modulate cancer outcome
through exosome-dependent stroma–tumor communication.
Discussion
Exosomes constitute a means by which tumor cells and associ-
ated stroma not only communicate locally but also influence and
transform distant locations or “niches” and even modulate or-
ganismal responses systemically (Costa-Silva et al., 2015;
Hoshino et al., 2015; Peinado et al., 2012). Despite their ubiquity,
the mechanisms underlying exosome biogenesis, cargo sorting,
and function remain elusive. Here, we identify Cav1 as a mod-
ulator of exosome biogenesis through the regulation of choles-
terol content in MVBs, which allows the generation of different
exosome subpopulations and exosome cargo specification
(mainly specific ECM proteins) with subsequent functional
impact. Our data demonstrate that the presence of Cav1 within
exosomes is favored by its endocytosis through Tyr14 phos-
phorylation. This promotes Cav1 targeting to the MVB outer
membrane, where a second mechanism is activated that re-
quires the presence of ubiquitination-targeting N-terminal
domain lysine residues; this second mechanism sorts Cav1
into ILVs for exosome generation. Cav1 would act as a “cho-
lesterol rheostat” in MVBs, thus increasing the plasticity of this
compartment and enabling the segregation of different exo-
some populations. Cholesterol titration in this compartment
could also determine exosome cargo specification by modulat-
ing ER-MVB contacts. Cav1-dependent exosomal ECM deposi-
tion elicits both local ECM deposition and the generation of
distant ECM-enriched regions, supporting a novel role of Cav1
in stromal remodeling. This exosomal ECM deposition pro-
motes protrusiveness and active migration of targeted tumor
cells by increasing cell scattering, suggesting that these mech-
anisms contribute to tumor cell invasiveness and favor the
nucleation of new ECM stromal niches (Fig. 8 C).
TnC is a key component involved in promoting exosome-
dependent tumor invasion. TnC matrix deposition by Cav1-
expressing fibroblasts strictly required intact exosome biogene-
sis and secretion. Our data support a model whereby the ER/Golgi
compartment is a major direct supplier of TnC to exosomes and
rule out incorporation from routes bypassing de novo synthesis,
such as internalization from the extracellular space. Supported by
studies performed in breast cancer cell lines (Campos et al., 2018),
our results demonstrate that Cav1 regulates a general mechanism
for exosome cargo specification, especially relevant for TnC sort-
ing and secretion. Our results suggest that Cav1-dependent exo-
somal TnC secretion has a dual effect on tumor progression
(Fig. 7): (1) local deposition of TnC at the tumor-invasive front
presumably induces tumor cell migration away from the tumor
mass (see Fig. 7), as observed upon direct addition of recombinant
soluble TnC (Nagaharu et al., 2011); additionally, (2) Cav1-dependent
exosome–mediated TnC deposition over large distances might
contribute to the “priming” of stromal niches before the arrival of
cancer cells, forming a “landing dock” for subsequent metastatic
growth (Costa-Silva et al., 2015; Sceneay et al., 2013). We show
that IV injection of exosomes derived fromWT fibroblasts, but not
from Cav1KO cells, can efficiently promote direct TnC–matrix
deposition in distant organs (Fig. 8). Further investigation is re-
quired to confirm whether these ECM stromal niches have an
impact on metastasis in vivo.
A pathway for caveolae internalization (Chaudhary et al.,
2014) has been described in which caveolae are disassembled
and Cav1 is internalized and ubiquitinated, followed by accu-
mulation at the internal membrane of LEs/MVBs (Hayer et al.,
2010; Hill et al., 2008). Interestingly, Cav1 is also targeted to LEs
by perturbations of lysosomal pH and changes in cholesterol
content, with no changes in Cav1 degradation rate, raising the
possibility of alternative fates for this Cav1 pool (Mundy et al.,
2012; Pol et al., 2020). The changes in Cav1-MVB colocalization
we observed (Fig. 1 and Fig. S1) are compatible with a scenario
whereby a significant proportion of internalized Cav1 is sorted
into MVBs, in part to be incorporated into exosomes. However,
at present we cannot rule out that other intracellular compart-
ments, such as the ER, may also be a source of exosomal Cav1.
Cav1 binds cholesterol with high affinity (Murata et al., 1995),
and its ability to move between different compartments might
corresponding increased intracellular accumulation (white arrowheads) in Cav1KD and Cav1KO MEFs (scale bar, 10 µm). (B) TnC deposition of WT MEFs
treated with U18666A determined by Z-stack projection confocal microscopy (scale bar, 40 µm). (C) Extracellular TnC deposition in fibers produced by
Cav1WT, Cav1KO, and U18666A-treated Cav1WT MEFs (mean ± SD; n = 8). (D) Western blot analysis of TnC expression in exosomes secreted by indicated
genotypes. Quantification: mean ± SEM; n = 6. (E) Effect of 5-d exposure to the exosome inhibitors dmA (75 nM) and GW4869 (10 µM) on TnC matrix de-
position (red) by WT MEFs (scale bar, 20 µm). Right: chart shows extracellular TnC fiber deposition (mean ± SEM; n = 12). (F) Z-stack of confocal images
showing the effect of 5-d exposure to dmA (75 nM) and GW4869 (10 µM) on FNmatrix deposition (green) by WTMEFs (scale bar, 50 µm). Bottom: chart shows
extracellular FN fiber deposition (mean ± SEM; n = 5). (G) Representative Z-stack projection of confocal images showing the effect of siRNAs targeting Tsg101
and neutral nSMase1 and 2 on TnC matrix deposition by WT MEFs (red; scale bar, 20 µm). The chart to the right shows extracellular TnC deposition in fibers
measured as in C (mean ± SEM; n = 6). n.s., not significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 5. Exosomal incorporation of TnC occurs intracellularly via the ER-MVB route. (A) Left: Western blot analysis of TnC and FN expression in lysates
from TnCWT and TnCKO fibroblasts. Right: CDMs were generated from TnCWT and TnCKO cells as described in Materials and methods, and TnCWT and
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contribute to the regulation of cholesterol fluxes in cells
(Pfrieger and Vitale, 2018; Pol et al., 2005). Our data support that
Cav1 dictates the levels of free cholesterol in LE/MVB mem-
branes, conferring the required plasticity for the generation of
ILVs of varying size and favoring the sorting of ECM compo-
nents onto exosomes for their secretion (Fig. 2, Fig. S2, and Fig.
S3). Furthermore, artificial manipulation of cholesterol levels at
LE/MVB, either by disrupting ER-endosome MCSs (Fig. 6 and
Fig. S5 D), by pharmacologically blocking cholesterol trafficking
at the endosomal compartment (Fig. 2; Fig. 4, B and C; Fig. S2 F;
and Fig. S4 H), or by exogenous loading with LDL-cholesterol
(Fig. S4, G and I), had a profound effect on the intracellular
trafficking and exosomal secretion of ECM exosome cargo. This
suggests a model whereby the control of cholesterol levels at
endosomes/MVBs is integral to the regulation of exosome-
mediated ECM deposition, as recently described for other sig-
naling events and functions at these intracellular compartments
(Lim et al., 2019; Eden et al., 2016). Of note, Cav1 at ER-
mitochondria MCS regulates the recruitment of sterol metabo-
lism complexes and cholesterol accumulation (Sala-Vila et al.,
2016). Further investigation will be required to better define the
mechanistic details of the interplay between cholesterol traf-
ficking and exosome biogenesis and downstream functions, of
which Cav1 appears to be a key player.
Interestingly, among identified Cav1-dependent exosomal
cargoes, collagens are less abundant than other ECM compo-
nents. Collagen secretion requires specific assembly mecha-
nisms operating through the COPII biosynthetic/secretory
machinery (Malhotra and Erlmann, 2015) and is thus unavail-
able to the exosome pathway (Fig. 3, Fig. 4, and Fig. S3). These
pathways might in fact be oppositely regulated by Cav1, since a
negative correlation has been described between Cav1 expres-
sion and collagen deposition in chronologically aged skin and
during fibrosis (Gvaramia et al., 2013; Lee et al., 2015). Sup-
porting our observation that exosomes can act as carriers of
some ECM proteins, a recent study demonstrated exosomal se-
cretion of FN through its binding to integrin α5β1; however, the
function and underlying mechanism of this sorting were not
determined (Lobert et al., 2010; Sung et al., 2015). Our data point
to incorporation of TnC into ILVs through its sorting from the
biosynthetic route to the MVB compartment, excluding the
possibility of an extracellular origin through internalization or
by direct binding to exosomes once they are released (Fig. 5).
Previous studies demonstrated high levels of Cav1-expressing
exosomes in the plasma of melanoma patients (Logozzi et al.,
2009). We propose that relative levels of Cav1-expressing exo-
somes could be a valuable prognostic marker of metastasis and
tumor malignancy, as well as other cholesterol-related diseases.
Our findings suggest new potential opportunities for diagnosis,




Monoclonal anti-Cav1 (#3267) and anti-Alix (#2171) antibodies
were from Cell Signaling Technology. Anti-LBPA was from
Echelon (Z-SLBPA). Anti-CD63 (ab1318), antiflotillin (ab13349),
antiperiostin (ab14041), anticalreticulin (ab2907), anti-PTRF
(ab48824), and anti-Tsg101 (ab83) were from Abcam. Anti-
GM130 (610823), anti–py14-Cav1 (611339), anticadherin (610181),
and antivimentin (550513) were from BD Transduction. Anti-
tubulin (T-9026), anti-FN (F3648), anti-Tenascin (Clone Mtn-12,
T3413), and anti–smooth muscle actin (A5228) were from Sigma.
Anti-Tenascin was also from Millipore (AB19011). Anti-nSMase1
(sc-377135) and anti-nSMase2 (sc-166637) were from Santa Cruz.
Alexa Fluor 488-, 546-, and 647-conjugated phalloidin were from
Life Technologies. GW4869 (567715) was from Calbiochem, and
dmA (A4562) and U18666A (U3633) were from Sigma. Matrigel
(354230) was from Becton Dickinson, and Collagen I from rat tail
(354249) was from Corning. Filipin was from Sigma (F4767).
Cell culture
MEFs derived from Cav1WT and Cav1KO littermate mice used
throughout this study have been previously described (del Pozo
et al., 2005). TnCWT and TnCKO MEFs were provided by our
collaborator Dr. Gertraud Orend. PTRFKO cells were provided by
Dr. Parton (Institute for Molecular Bioscience, University of
Queensland, St. Lucia, Australia) and were reconstituted with
the retroviral expression vector pMIGR1. COS7 cells were from
ATCC. MEFs and COS7 cells were cultured in DMEM supple-
mented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml
streptomycin at 37°C in a humidified 5% CO2–95% air incubator.
The breast cancer–associated fibroblast line CCD-1069S and the
breast tumor cell line MDA-MB468 were from ATCC and were
cultured in DMEM/F-12 supplemented with 10% FBS, 100 U/ml
penicillin, and 100 µg/ml streptomycin. CCD-1069S fibroblasts
stably expressing shRNA targeting Cav1 or a scramble siRNAwere
generated by lentiviral infection as reported in Goetz et al. (2011).
All the cell lineswere routinely checked formycoplasma infection.
siRNA silencing
siRNA silencing was performed using 20 nM siRNA and Lip-
ofectamine RNAiMAX Reagent (Thermo Fisher Scientific)
TnCKO cells were plated on these CDMs for further 24 h as depicted. CDMs were labeled with TnC (in red), and the plated cells were stained with F-actin (in
gray; scale bar, 50 µm). (B) Western blot analysis of TnC and FN in total lysates (CDM + plated cells) and cells plated on CDM and isolated by trypsinization.
Tubulin was used as a loading control. Cells were cultured on decellularized CDMs for 24 h prior to analysis. (C) Interaction assay of purified exosomes with
TnC-rich or TnCKO CDMs. The scheme shows the assay protocol. Western blot shows analysis of TnC and FN binding to exosomes. (D) Subcellular frac-
tionation analysis of intracellular TnC distribution in WT (treated with either vehicle or GW4869) and Cav1KO cells, using indicated markers. The boxed area
denotes MVB-enriched fractions. Plots show the relative amount of TnC in each fraction with respect to the total TnC (normalized to 1) present in MVB-
enriched fractions across conditions (mean ± SD; n = 3). (E) Colocalization between TnC (red) and calreticulin (green) was analyzed in Cav1WT MEFs treated
with GW4869 alone or in combination with the lysosomal inhibitor chloroquine (scale bar, 50 µm; zoomed views scale bar, 20 µm). Chart shows Pearson´s
correlation coefficient for colocalization TnC and calreticulin (mean ± SD; n = 3). CNTRL, control. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 6. Cholesterol modulation at endosomal compartment/MVBs controls exosome-mediated TnC deposition. (A) Disruption of cholesterol
transfer from the ER to the endosomes upon knocking down VAPA or ORP1L tethers in Cav1KOMEFs attenuates cholesterol accumulation as assessed by filipin
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according to the manufacturer’s protocol, and cells were cul-
tured for 2–3 d. siRNAs targeting mouse Tsg101, nSMase1, and
nSMase2 were SMARTpool ON-TARGET plus reagents from
Dharmacon (Tsg101 Cat. L-049922-01-0005; nSMase1 or Smpd2
Cat. L-044206-01-0005; and nSMase2 or Smpd3 Cat. L-059400-
01-0005). The control siRNA was ON-TARGET plus non-
targeting pool (Dharmacon Cat. D-001810-10-05). Cav1 was
silenced with an siRNA from Dharmacon (seq. 59-GAGCUUCCU
GAUUGAGAUU-39) and an enzymatically prepared siRNA from
Sigma (EHU031251). esiRNAs targeting the VAPA:ORP1L tether
complexwere purchased fromSigma (EMU053971 and EMU012501,
respectively).
Isolation and characterization of exosomes released
by fibroblasts
Exosomes were isolated from cultured fibroblasts grown in
exosome-free culture medium. To remove detached cells, con-
ditioned medium was collected and centrifuged at 300 g for
10 min at 4°C. The supernatant was collected and centrifuged at
2,000 g for 20 min at 4°C. The supernatant was then centrifuged
at 10,000 g at 4°C for 30 min to completely remove contami-
nating apoptotic bodies, microvesicles, and cell debris. The clari-
fied medium was then ultracentrifuged at 110,000 g at 4°C for
70 min to pellet exosomes. The supernatant was carefully re-
moved, and crude exosome-containing pellets were washed in ice-
cold PBS. After a second round of ultracentrifugation, the resulting
exosome pellets were resuspended in the desired volume of PBS.
For further purification, exosomes were ultracentrifuged on
a discontinuous sucrose gradient including sucrose concen-
trations of 0.25M, 0.5M, 0.8M, 1.16M, 1.3M, and 2M in 20mM
Hepes, pH 7.4. Exosome samples were laid on the bottom of the
gradient in the 2-M sucrose fraction, followed by centrifugation
at 200,000 g for 18 h. 11 individual 1-ml gradient fractions were
manually collected. Fractionswere diluted in PBS and centrifuged at
110,000 g for 1 h at 4°C, and the resulting pellets were resuspended
and analyzed. Alternatively, an equal volume of cold acetone was
added to each fraction, and the proteins were precipitated for 2 h at
−20°C. Protein pellets were collected by centrifugation at 16,000 g
for 10 min and air-dried to eliminate acetone traces. The protein
precipitates were monitored by Western blot for the expression of
the exosomal markers Alix and Tsg101.
Alternatively, a discontinuous iodixanol gradient was used.
To prepare the discontinuous iodixanol gradient, 40% (wt/vol),
20% (wt/vol), 10% (wt/vol), and 5% (wt/vol) solutions of iodix-
anol were made by diluting stock solutions of Optiprep (60%
[wt/vol] aqueous iodixanol) with 0.25 M sucrose/10 mM Tris,
pH 7.5. The gradientwas formed by adding 3ml of 40% iodixanol
solution to a 14 × 89–mm polyallomer tube (Beckman Coulter),
followed by careful layering of 3 ml each of 20% and 10%
solutions and 2.5 ml of 5% solution. Exosome preparation was
overlaid onto the top of the gradient and centrifugation per-
formed at 100,000 g for 18 h at 4°C. 12 individual 1-ml gradient
fractions were collected manually from the top to the bottom.
Fractions were diluted with 1 ml PBS and precipitated with 2 ml
cold acetone for 3 h at −20°C. Protein pellets were collected by
centrifugation at 16,000 g for 10 min and air-dried to eliminate
acetone traces. The protein precipitates were monitored by
Western blot for the expression of exosomal markers Alix,
Tsg101, flotillin-1, and the negative control GM130 (Golgi).
In all experiments, the exosomes used corresponded to the
total exosome pellets resulting from the serial centrifugation
steps; usually, 106 exosome particles were added per cell. Exo-
some uptake was performed in exosome-free medium.
Exosome concentrations and size distributions were deter-
mined by Nanoparticle Tracking Analysis (Nanosight).
Western blot analysis
Western blot samples were prepared with conventional 5×
Laemmli sample buffer brought to 1× when mixed with the
sample. The 5× Laemmli sample buffer is composed of 60 mM
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol,
and 0.01% bromophenol blue.
Cell or exosome proteins were resolved by SDS-PAGE and
transferred to nitrocellulose membranes. Blots were incubated
for 2 h in PBS containing 5% skimmed milk and overnight with
primary antibodies (typically diluted 1:1,000). After incubation
(2 h) with horseradish peroxidase–conjugated goat anti-rabbit or
goat anti-mouse antibody, signal on washed blots was detected
by enhanced chemiluminescence (GE Healthcare). Band inten-
sities were quantified with Image J software.
Intracellular lysate analysis
To prepare lysates containing only proteins from the cell inte-
rior, plated cells were treated with trypsin to eliminate proteins
in the extracellular space. Detached cells were washed with PBS
and resuspended in loading buffer for Western blot analysis. For
total lysates comprising cell and ECM proteins, cells were scra-
ped directly from the plate in loading buffer.
PKH67 labeling of exosomes
Purified exosomes were labeled with the green fluorescent dye
PKH67 (Sigma; MIDI67) according to the manufacturer’s proto-
col. After staining, unbound PKH67 was removed with columns
from Thermo Fisher Scientific (4484449).
EM
Exosomes were visualized by TEM according to the method of
Théry et al. (2006). The exosome suspension was fixed in 2%
(grayscale) and LBPA (green) staining (scale bar, 20 µm). Lower panel rows show zoomed thumbnails of the indicated regions of interest (scale bar, 6 µm).
Charts on the right show quantitative analysis of filipin mean fluorescence intensity in MVBs (upper) and total MVB area (lower). Error bar are means ± SD; n = 3.
(B) Confocal analysis of TnC distribution (in red) and LBPA (in green) in VAPA-depleted Cav1KO MEFs electroporated with Rab5(Q79L) (gray; scale bar, 10 µm).
Rightmost panels show zoomed views of endosomes/MVBs (scale bar, 5 µm). Plots show pixel intensities for Rab5(Q79L) (gray) and TnC (red) along the indicated
lines. (C) Z-stack projection of confocal images showing the effect on TnC fiber deposition (red) upon RNAi-mediated depletion for VAPA and ORP1L (scale bar,
10 µm). The chart shows extracellular TnC fiber deposition by either WT or Cav1KO MEFs upon depletion of indicated tethers (mean ± SEM; n = 3). n.s., not
significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 7. TnC deposition mediated by exosomes promotes tumor cell invasiveness. (A–G)MDA-MB468 breast tumor cells were incubated with PKH67-
labeled exosomes derived from WT or Cav1KO MEFs or with PBS (control). (A) Microscopy images of exosome (green) uptake by MDA-MB468 cells and
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PFA and transferred to formvar/carbon–coated EM grids. After
20 min, grids were placed sample-face down for 2 min in a 100-
μl drop of PBS on a sheet of parafilm. Grids were then trans-
ferred to 1% glutaraldehyde for 5 min and then washed with
distilled water. Samples were contrasted in 2% uranyl acetate
and examined by TEM.
Spheroid formation assay
After trypsinization, MDA-MB468 cells were resuspended in
exosome-free DMEM, counted, and adjusted to the desired
concentration (usually 5 × 103 cells/ml). A 20-µl final volume
was prepared with 5× methyl cellulose prepared in exosome-
free medium, the MDA-MB468 cell suspension, and the
desired number of exosomes (usually 1 × 106 particles). The
mixture was carefully deposited in a drop on the inner surface of a
100-mm dish lid. The plate lid was placed on a plate containing
10 ml PBS to humidify the culture chamber. Under gravity, cells
aggregated at the bottom of the hanging drop. After 24 h, the re-
sulting cell aggregates were lifted with a pipette. For 2D spheroid
migration assays, the aggregates were seeded on a 96-well plate to
monitor cell migration from the spheroid by phase-contrast time-
lapse video microscopy. Alternatively, aggregates were seeded on
collagen or Matrigel gels as described below. In all assays, no ad-
ditional exosomes were added to the medium apart from the
exosomes used during spheroid generation.
Collagen embedding
High-density rat-tail type I collagen (Corning) was diluted to
2 mg/ml. This solution self-polymerizes to form a gel after
20–30 min at 37°C. Tumor cell spheroids were transferred to
25 µl unpolymerized collagen in the wells of a μ-slide angio-
genesis plate (ibidi). After 30 min, 40 µl medium was added over
the top of the gel. Mediumwas replaced every 48 h. Spheroids were
imaged every 24 h for the duration of the experiment. Spheroid
diameter was measured from captured images with ImageJ.
For Matrigel embedding assays, spheroids were transferred
to a 25-µl 1:1 mix of Matrigel and medium.
Wound closure assay
For the wound healing assay, confluent monolayers were scra-
ped with a 0.1–2-µl pipette tip in the presence of mitomycin C,
and wound closure was monitored by capturing images at 10-
min intervals.
CDM generation
3D matrices reminiscent of in vivo ECM were prepared as
published (Beacham et al., 2007; Castelló-Cros and Cukierman,
2009; Goetz et al., 2011). Briefly, 2.5 × 105 cells/ml were plated on
chemically cross-linked gelatin on tissue culture dishes or cov-
erslips and maintained in confluence for 6 d. Cells were sup-
plemented every 48 h with 50 mg/ml fresh L-ascorbic acid to
stabilize ECM components, thus facilitating collagen production
and polymerization. The resulting 3D cultures were checked for
quality by immunofluorescence, or cells were removed from the
matrix by alkaline detergent extraction, yielding cell-free 3D
matrices for further analysis.
For analysis of exosome binding to preexisting CDMs, CDMs
from TnCWT and TnCKO MEFs were obtained as previously
indicated. Cell-free 3D matrices were scrapped in 1 ml PBS and
homogenized passing several times through a syringe (0.5 × 16
mm). Cell-free 3D matrix corresponding to a p150 plate was
incubated with 1 × 108 exosomes per condition for 1 h at 37°C.
After that, samples were ultracentrifuged at 10,000 g for 30 min
to remove unbound cell-free 3D matrix components followed by
an ultracentrifugation at 110,000 g for 70 min to recover exo-
somes. Obtained exosomes were loaded with equal amount of
Laemmli buffer and analyzed by SDS-PAGE.
For assessing potential TnC internalization through endo-
cytic trafficking, cells from the indicated genotypes were plated
onto previously isolated decellularized CDMs (obtained as de-
scribed above) and cultured for 24 h in the incubator at 37°C.
Cells were then trypsinized and rinsed with PBS in order to
remove any extracellular nonendocytosed ECM proteins. Fi-
nally, cells were resuspended into denaturing, reducing SDS-
PAGE loading buffer to obtain “cell lysates” ready for Western
blot analysis.
Proteomic analysis
Lysates and exosomes derived from WT and Cav1−/− MEFs were
digested using the filter-aided sample preparation protocol
(Wiśniewski et al., 2009). Briefly, samples were dissolved in
50 mM Tris-HCl, pH 8.5, 4% SDS, and 50 mM DTT, boiled for
10 min, and centrifuged. Protein concentration in the superna-
tant was measured with the Direct Detect Spectrometer (Milli-
pore). About 100 µg protein was diluted in 8 M urea in 0.1 M
Tris-HCl, pH 8.5 (urea buffer; UA), and loaded onto 30-kD
centrifugal filter devices (filter-aided sample preparation
deposition of exosome-delivered TnC (red) in areas surrounding tumor cells. Scale bar, 30 µm. (B) Phenotypic changes in MDA-MB468 cells 36 h after exposure
to fibroblast-derived WT and Cav1KO exosomes. Cells were stained for the epithelial-mesenchymal transition marker E-cadherin; nuclei were stained with
Hoechst. Zoomed images show E-cadherin redistribution from cell-cell contact sites to intracellular compartments (scale bar, 10 µm). E-cadherin and other
epithelial-mesenchymal transition markers were determined by Western blot. Chart shows the changes in E-cadherin upon treatment with PBS (CNTRL), WT,
or Cav1KO exosomes (mean ± SD; n = 3). (C) Z-stack confocal images of TnC deposition (red) within 3D MDA-MB468 spheroids generated in the presence of
WT, Cav1KO, or Cav1KD exosomes. Nuclei are stained with Hoechst (blue; scale bar, 150 µm). Zoomed images show a clear distribution of TnC deposits (scale
bar, 50 µm). White arrowheads: TnC fibers. Right: chart shows extracellular TnC fiber deposition (mean ± SEM; n = 3). (D) Phase-contrast image of MDA-
MB468 spheroid migration (scale bar, 175 µm). Spheroids were generated in the presence of the indicated exosomes and cultured for 72 h. Graph shows
quantitative analysis of spheroid migration (mean ± SEM; n = 11). (E and F) Invasiveness of MDA-MB468 spheroids generated in the presence of fibroblast-
derived WT or Cav1KO exosomes. Invasiveness was assessed in Matrigel (E; phase-contrast microscopy and quantified; mean ± SEM; n = 26 spheroids per
condition; scale bar, 150 µm) or collagen type I gel (F; immunofluorescence; arrowheads indicate areas of cell invasion; mean ± SEM; n = 24 spheroids per
condition; scale bar, 100 µm). (G) Invasiveness of MDA-MB468 spheroids generated in the presence of fibroblast-derived TnCWT and TnCKO exosomes.
Arrowheads indicate areas of cell invasion. The chart shows quantification of MDA-MB468 spheroid invasiveness into collagen (mean ± SD; n = 15 spheroids
per condition; scale bar, 150 µm). CNTRL, control; n.s., not significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 8. Cav1-loaded fibroblast-derived exosomes deposit TnC in vivo in a tissue-specific manner. (A) Treatment protocol. (B) Fluorescence mi-
croscopy of liver sections frommice injected in the tail vein with Cav1WT or Cav1KO fibroblast-derived exosomes or with PBS (scale bar, 60 µm; zoomed views,
scale bar, 30 µm). Exosome foci are green. White arrowheads indicate regions of TnC deposition. All images are representative of nine random fields from two
independent experiments. (C) Proposed role of Cav1 in exosome-mediated ECM deposition. (C I) Endocytosed Cav1 enters the MVB compartment, where it
promotes exosome heterogeneity in size and composition, favoring the entry of specific ECM components. (C II) Cav1WT fibroblast-derived exosomes
stimulate protrusive activity and motility of breast cancer cells by nucleating local ECM (TnC) deposition in areas surrounding the tumor cells. (C III) Cav1WT
fibroblast-derived exosomes also generate ECM-rich deposits at long distances from their source in vivo, generating sites of possible future metastasis.
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protein digestion kit). The denaturation buffer was removed by
washing three times with UA. Proteins were then alkylated by
incubation in 50 mM iodoacetamide in UA for 20 min in the
dark, and excess alkylation reagents were eliminated by wash-
ing three times with UA and three additional times with 50 mM
ammonium bicarbonate. Proteins were digested overnight at
37°C with modified trypsin (Promega) in 50 mM ammonium
bicarbonate at a 50:1 protein:trypsin (wt/wt) ratio. The resulting
peptides were eluted by centrifugation with 50 mM ammonium
bicarbonate (twice) and 0.5 M sodium chloride. Trifluoroacetic
acid was added to a final concentration of 1%, and the peptides
were finally desalted onto C18 Oasis-HLB cartridges and dried
down for further analysis.
Multiplexed isobaric labeling
For the quantitative analysis, tryptic peptides were dissolved in
triethylammonium bicarbonate buffer, and the peptide con-
centration was determined by measuring amide bonds with the
Direct Detect system. Equal amounts of each peptide sample
were labeled using the 4-plex iTRAQ Reagents Multiplex Kit
(Applied Biosystems). Briefly, each peptide solution was inde-
pendently labeled at room temperature for 1 h with one iTRAQ
reagent vial (mass tag 114, 115, 116, or 117) previously recon-
stituted with ethanol. After incubation at room temperature for
1 h, the reaction was stopped with diluted trifluoroacetic acid
and peptides were combined. Samples were concentrated in a
Speed Vac, desalted onto C18 Oasis-HLB cartridges, and dried
down for mass spectrometry (MS) analysis.
MS
Digested peptides were loaded into the liquid chromatography–
tandem MS (LC-MS/MS) system for on-line desalting onto C18
cartridges and analyzed by LC-MS/MS using a C-18 reversed-
phase nano-column (75 µm I.D. × 25 cm, 2 µm particle size, Ac-
claim PepMap RSLC, 100 C18; Thermo Fisher Scientific) in a
continuous acetonitrile gradient consisting of 0%–30% B for
240 min and 50%–90% B for 3 min (A = 0.5% formic acid; B = 90%
acetonitrile, 0.5% formic acid). A flow rate of 200 nl/minwas used
to elute peptides from the reverse phase nano-column to an
emitter nanospray needle for real-time ionization and peptide
fragmentation in an Orbitrap QExactive mass spectrometer
(Thermo Fisher Scientific). During the chromatography run, we
examined an enhanced Fourier transform-resolution spectrum
(resolution = 70,000) followed by the higher-energy collisional
dissociationMS/MS spectra from the 20most intense parent ions.
Dynamic exclusion was set at 40 s. For increased proteome cov-
erage, labeled samples were also fractioned by cation exchange
chromatography (Oasis HLB-MCX columns); fractions were de-
salted and analyzed using the same system and conditions de-
scribed before.
Protein identification and quantification
All spectra were analyzed with Proteome Discoverer (version
1.4.0.29; Thermo Fisher Scientific) using SEQUEST-HT (Thermo
Fisher Scientific). The Uniprot database, containing all mouse
sequences (March 3, 2013), was searched with the following
parameters: trypsin digestion with two maximum missed
cleavage sites; precursor and fragment mass tolerances of 2 D
and 0.03 D, respectively; methionine oxidation as a dynamic
modification; and carbamidomethyl cysteine and N-terminal
and Lys iTRAQ modifications as fixed modifications. Peptides
were identified using the probability ratio method (Mart́ınez-
Bartolomé et al., 2008), and false discovery rate was calculated
using inverted databases and the refined method (Navarro
et al., 2014) with an additional filtering for a precursor mass
tolerance of 15 ppm (Bonzon-Kulichenko et al., 2015). Identified
peptides had a false discovery rate ≤1%.
Proteins were quantified from reporter ion intensities and
quantitative data analyzed with QuiXoT, based on the weighted
spectrum, peptide, and protein statistical model (Garćıa-Marqués
et al., 2016). In this model, protein log2-ratios are expressed as
standardized variables (i.e., in units of SD according to their es-
timated variances [Zq values]). Functional class enrichment was
assessed using the Enrichr package (Chen et al., 2013), and net-
work depiction of annotated relationships among hits was re-
trieved from the STRING v.11 resource).
MS raw files and msf search files have been deposited in the
PeptideAtlas repository (accession no. PASS01614; http://www.
peptideatlas.org/PASS/PASS01614).
LC-MS/MS analysis of exosome glycerophospholipids
Exosome samples fromWT and KOmice corresponding to 2.5 µg
protein were used. Before lipid extraction, the following internal





phosphoglycerol, according to the method of Bligh and Dyer
(1959). After evaporation of organic solvent under vacuum,
the lipids were redissolved in 50 µl solvent mixture (75% A,
25% B), and 40 µl was injected into an Agilent 1260 Infinity
high-performance liquid chromatograph equipped with an
Agilent G1311C quaternary pump and an Agilent G1329B Auto-
sampler. The column was a FORTIS HILIC (150 × 3 mm, 3-µm
particle size; Fortis Technologies) protected with a Supelguard
LC-Si (20 mm × 2.1 mm) guard cartridge (Sigma). Glycer-
ophospholipids and sphingomyelin were separated according to
the procedure described by Axelsen and Murphy (2010), with
minor modifications. Briefly, the mobile phase consisted of a
gradient of solvent A (hexanes:isopropanol, 30:40, by vol) and
solvent B (hexanes:isopropanol:20 mM AcONH4 in water, 30:
40:7 by vol). The gradient started at 75% A from 0 to 5min, then
decreased from 75% A to 40% A at 15 min, from 40% A to 5% A at
20 min, holding at 5% until 40 min, and increasing to 75% at
41 min. The column was then reequilibrated by holding at 75%
A for an additional 14 min before the next sample injection. The
flow rate through the column was fixed at 0.4 ml/min, and this
flow entered into the electrospray interface of an API2000
triple quadrupole mass spectrometer (Applied Biosystems). The
source parameters were set as follows: ion spray voltage,
−4,500 V; curtain gas, 20 psi; nebulizer gas, 35 psi; desolvation
gas, 65 psi; and temperature, 400°C. Phospholipid species were
analyzed in Q1 with negative ionization. Compound parameters
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were fixed for all analyzed species: declustering potential, −65 V;
entrance potential, −10 V; focusing potential, −300 V; and collision
cell exit potential, −10 V. Phospholipid species were detected as
[M-H]− ions except for phosphatidylcholine and sphingomyelin
species, which were detected as [M+OAc]− adducts. For quantifi-
cation, chromatographic peaks of each species were integrated
and compared with the peak area of the internal standard corre-
sponding to each phospholipid class. Since bis(monoacylglycerol)
phosphate and sphingomyelin internal standards were unavail-
able at the time of analysis, these species were quantified using
1-heptadecanoyl-2-arachidonoyl-3-phosphoglycerol and 1,2-
dipentadecanoyl-sn-glycero-3-phosphocholine standards, respec-
tively. MS source raw data have been deposited in the MetaboLights
public repository under accession no. MTBLS1969.
Cholesterol quantification by LC-MS/MS
To quantify the amount of cholesterol in exosomes, 25 µl of 19.68
µg/ml cholesterol (d7) solution in methanol (SPLASH LipidoMIX
Internal Standard; Avanti) was added to each sample. Choles-
terol was extracted, and proteins were precipitated by adding
475 µl cold methanol–ethanol (1:1 vol/vol). Samples were vortex-
mixed, sonicated during 3 min, and incubated on ice for 20 min.
Finally, supernatants were collected by centrifugation at
18,400 g for 20 min at 8°C and dried in SpeedVac (Savant
SPD131DDA concentrator; Thermo Fisher Scientific) for 2 h at
room temperature.
Metabolomics analysis was performed using an Ultimate
3000 HPLC system coupled to an Orbitrap ELITE Hybrid Ion
Trap-Orbitrap Mass Spectrometer (Thermo Fisher Scientific).
For chromatographic separation, an Agilent RP, Hi Recovery
column (100 × 0.5 mm, 5 µ) was used. Cholesterol was identified
by LC-MS/MS mode and quantified according to the response
factor of the respective internal standard.
Subcellular fractionation
Intracellular compartments were separated by sucrose density
gradient centrifugation. Cells were washed three times in
10 mM Tris-HCl, pH 7.5, and 0.5 mM MgCl2 and then scraped
and resuspended in 50 mM Tris-HCl, pH 7.5, and 0.25 M su-
crose. Cells were homogenized with 30 strokes using a Dounce
homogenizer. The homogenates were then centrifuged at
3,000 g for 15 min at 4°C. The supernatant was placed over a
continuous sucrose gradient (2 M at the bottom; 0.25 M at the
top), and samples were separated at 100,000 g for 18 h in an
SW40 rotor (Beckman Coulter) at 4°C. After centrifugation, 1-ml
fractions were collected from the tube, yielding a total of 12
fractions. Cold acetone (1 ml) was added to each tube, and the
homogeneous mixture was allowed to precipitate at −20°C for
2 h. The samples were centrifuged at 16,000 g at 4°C, and the
protein pellets were allowed to dry for 2 h. The protein pre-
cipitates were then analyzed by SDS-PAGE for proteins, in-
cluding the ER marker calreticulin and the MVB marker CD63.
Preparation of DRM fractions
DRMs from exosomes derived from Cav1WT and Cav1KO MEFs
were purified as described in Navarro-Lérida et al. (2002), with
the Triton X-100 concentration reduced from 1% to 0.5%.
Transwell migration assay
The transwell migration assay was performed with Boyden
chambers containing an 8-µm pore-size polycarbonate filter
(Corning Costar). Serum-free medium (300 µl) with or without
exosomes was placed in the wells of a 24-well plate. The trans-
well inserts were placed in the wells, and 5 × 104 MDA-MB468
cells in 200 µl serum-free medium were added to the upper
chamber. After incubation for 24 h, cells on the lowermembrane
surface were fixed and stained with crystal violet and counted
under a microscope.
Animal model
All animal procedures conformed to European Union Directive
86/609/EEC and Recommendation 2007/526/EC regarding the
protection of animals used for experimental and other scientific
purposes, enforced in Spanish law under Real Decreto 1201/
2005. Cav1WT and Cav1−/− exosomes were labeled with PKH67
and intravenously injected every day for 1 wk into the tail vein of
TnC−/− mice (Talts et al., 1999) bred into the FVB background.
After 4 d, lungs and livers were collected and embedded sections
were analyzed by immunohistochemistry with anti-TnC anti-
body (Sigma).
Immunofluorescence microscopy
Cells grown on glass coverslips were washed twice with PBS and
fixed for 15 min at room temperature in 4% PFA in PBS. Fixed
cells were washed extensively with PBS and permeabilized for
5 min in PBS containing 0.1% TritonX-100 and 2% BSA to reduce
nonspecific binding. Cells were incubated for 1 h at room tem-
perature in PBS containing 0.2% BSA with primary antibodies
(typically diluted 1:200). Subsequent washes and incubations
with Alexa Fluor 647 or 546 phalloidin or fluorescent secondary
antibodies were performed in PBS for 1 h at room temperature.
Coverslips were mounted in PermaFluor aqueous mounting
medium and examined with a Leica SPE, SP5, or SP8 confocal
microscope, typically through 40× (ACS APO 40.0× 1.15 oil) or
63× (ACS APO 63.0× 1.30 oil) objectives. A 100× objective (HC PL
Apo CS2 100×/NA 1.4 oil) was used for high-resolution imaging
in an SP8 confocal microscope.
Filipin staining and quantification
Cells were grown on glass coverslips. After fixing for 10 min at
37°C with 4% PFA in PBS, cells were permeabilized with 0.2%
BSA and 0.1% saponin in PBS (blocking solution) for 30 min.
Samples were then incubatedwith primary antibody (LBPA) and
fluorescently labeled–conjugated secondary antibodies for 1 h
each, interspersed with three washes in blocking solution. After
an additional wash in PBS, cells were incubated for 1 h with filipin
(50 µg/ml in PBS). After three washes in PBS, slides were
mounted in Fluoromount. Fiji software was used to quantify fili-
pin fluorescence intensity (http://fiji.sc/). Cells were segmented
based on LBPA staining. Filipin staining intensity in LBPA-positive
vesicles was measured after intensity thresholding.
Quantitative real-time PCR
Frozen tissues or cell lines were analyzed for specific gene ex-
pression using Sybr Green PCR Reagents (Applied Biosystems)
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and specific primers: mouse Tsg101 sense 59-TCTAACCGTCCG
TCAAACTGT-39, antisense 59-TTGTACCAGTGAGGTTCACCA-39;
mouse nuclear sphingomyelinase (nSMase) 2 sense 59-ACACGA
CCCCCTTTCCTAATA-39, antisense 59-GGCGCTTCTCATAGG
TGGTG-39; and mouse nSMase 1 sense 59-TGGGACATCCCCTAC
CTGAG-39, antisense 59-TAGGTGAGCGATAGCCTTTGC-39. Total
RNA was extracted from tissues or cells using the RNeasy kit
(Qiagen) and reverse-transcribed. Quantitative real-time PCR
was performed with a 7500Fast Real-Time PCR System. Relative
expression was normalized to GAPDH and hypoxanthine gua-
nine phosphoribosyl transferase.
Immunohistochemical staining
Harvested tissues were fixed in 4% PFA, processed through
graded sucrose, embedded in O.C.T. medium (Tissue-Tek), and
stored at −80°C. Frozen sections (20 µm) were dried for 10 min
at room temperature and blocked for 1 h in PBS containing 4%
chicken serum and 0.3% TritonX-100. Sections were stained
with anti-TnC antibody diluted 1:200 in blocking solution
overnight at 4°C. Samples were washed extensively in PBS,
0.15% TritonX-100 for at least for 3 h. Samples were then in-
cubated overnight with anti-rabbit Alexa Fluor 647 secondary
antibody (1:200), Alexa Fluor 546 phalloidin (1:500), and
Hoechst 33342 in blocking solution. After extensive washing,
sections were mounted in PermaFluor mounting medium.
Confocal Z-stack images were captured, and TnC deposits were
quantified.
Extracellular TnC and FN fiber quantification
The procedure for image processing and quantification of “fi-
berness” was developed as a macro in Fiji (ImageJ 1.50e x64).
Fiberness measures the amount of fiber-like structures in an
image, providing a readout that takes into account both the
density of fibers and their length independently of orientation.
Noise reduction first stabilizes the image background. The
structural information from the eigen values of the Hessian
matrix is then used to apply a Frangi vesselness filter76 to
enhance very thin, almost unidimensional tubular structures
(filter scale: σ = 0.179 µm, close to pixel size). The output is a
fiber-enhanced image in which each pixel contains a fiberness
score. M0 readout was computed as the mean fiberness score in
the whole image. The processing pipeline and extracted M0
measures are illustrated in Fig. S3 B.
LDL incorporation in vitro
Blood for LDL isolation was obtained from healthy volunteers
after informed consent in accordance with local ethics com-
mittee guidelines (Comité de Ética de la Investigación del In-
stituto de Salud Carlos III: CEI PI 12_2016-v2).
Fluorescently labeled human LDL was prepared as described
(Steffensen et al., 2015). Briefly, human blood from healthy
donors was collected in K3EDTA-containing tubes. After cen-
trifugation, plasma was collected, mixed with KBr, and layered
on a KBr density gradient column. The column was centrifuged
at 256,000 g for 18 h in an Optima L-100 ultracentrifuge
(Beckman Coulter). The 1.063-g/ml density layer containing
LDL was collected, purified on a PD10 column (17085101; GE
Healthcare), and conjugated to the fluorochrome Alexa Fluor
647. Alexa Fluor 647–LDL was purified on a PD10 column, and
purity was tested at the Centro Nacional de Investigaciones
Cardiovasculares Carlos III (CNIC) Proteomics Unit by LC-MS.
Cav1WT MEFs were cultured in DMEM supplemented with
2% FBS and loaded with Alexa Fluor 647–LDL to a final con-
centration of 200 µg/ml for 24 h (for TnC analysis at MVBs) or
for 48 h (for TnC deposition studies).
Statistical analysis
Error bars depict SEM. Statistical significance was determined
with GraphPad Prism by unpaired Student’s t test or Mann-
Whitney test, as indicated; *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Online supplemental material
Fig. S1 shows that internalization of Cav1 favors its entry into
exosomes. Fig. S2 shows that Cav1-positive exosomes display a
specific lipid/protein composition. Fig. S3 shows that exosome
inhibition favors intracellular TnC accumulation. Fig. S4 shows
that exosomes derived from CAFsmodulate ECM deposition. Fig.
S5 shows that disruption of ER-MVB contact sites modulates
TnC matrix deposition. Data S1 presents high-throughput com-
parative proteomics of cell lysates and exosomes derived from
either WT or Cav1KO fibroblasts. Data S2 presents high-throughput
comparative proteomics of exosomes derived from MDA-MB231 or
MDA-MB468 cells.
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Théry, C., S. Amigorena, G. Raposo, and A. Clayton. 2006. Isolation and
characterization of exosomes from cell culture supernatants and bio-
logical fluids. Curr. Protoc. Cell Biol. Chapter 3:Unit 3.22.
Trajkovic, K., C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel, F. Wieland, P.
Schwille, B. Brügger, and M. Simons. 2008. Ceramide triggers budding
of exosome vesicles into multivesicular endosomes. Science. 319:
1244–1247. https://doi.org/10.1126/science.1153124
Unlu, G., D.S. Levic, D.B. Melville, and E.W. Knapik. 2014. Trafficking
mechanisms of extracellular matrix macromolecules: insights from
vertebrate development and human diseases. Int. J. Biochem. Cell Biol. 47:
57–67. https://doi.org/10.1016/j.biocel.2013.11.005
van Niel, G., I. Porto-Carreiro, S. Simoes, and G. Raposo. 2006. Exosomes: a
common pathway for a specialized function. J. Biochem. 140:13–21.
https://doi.org/10.1093/jb/mvj128
Villarroya-Beltri, C., F. Baixauli, C. Gutiérrez-Vázquez, F. Sánchez-Madrid,
andM.Mittelbrunn. 2014. Sorting it out: regulation of exosome loading.
Semin. Cancer Biol. 28:3–13. https://doi.org/10.1016/j.semcancer.2014.04
.009
Wang, W., L. Yang, and H.W. Huang. 2007. Evidence of cholesterol accu-
mulated in high curvature regions: implication to the curvature elastic
energy for lipid mixtures. Biophys. J. 92:2819–2830. https://doi.org/10
.1529/biophysj.106.097923
Wiśniewski, J.R., A. Zougman, N. Nagaraj, and M. Mann. 2009. Universal
sample preparation method for proteome analysis. Nat. Methods. 6:
359–362. https://doi.org/10.1038/nmeth.1322
Wubbolts, R., R.S. Leckie, P.T. Veenhuizen, G. Schwarzmann, W. Möbius, J.
Hoernschemeyer, J.W. Slot, H.J. Geuze, and W. Stoorvogel. 2003. Proteo-
mic and biochemical analyses of human B cell-derived exosomes. Potential
implications for their function and multivesicular body formation. J. Biol.
Chem. 278:10963–10972. https://doi.org/10.1074/jbc.M207550200
Zanoni, M., F. Piccinini, C. Arienti, A. Zamagni, S. Santi, R. Polico, A. Bev-
ilacqua, and A. Tesei. 2016. 3D tumor spheroid models for in vitro
therapeutic screening: a systematic approach to enhance the biological
relevance of data obtained. Sci. Rep. 6:19103. https://doi.org/10.1038/
srep19103
Zimnicka, A.M., Y.S. Husain, A.N. Shajahan, M. Sverdlov, O. Chaga, Z. Chen,
P.T. Toth, J. Klomp, A.V. Karginov, C. Tiruppathi, et al. 2016. Src-
dependent phosphorylation of caveolin-1 Tyr-14 promotes swelling
and release of caveolae.Mol. Biol. Cell. 27:2090–2106. https://doi.org/10
.1091/mbc.E15-11-0756
Albacete-Albacete et al. Journal of Cell Biology 23 of 23









nic) user on 29 June 2021
Supplemental material
Albacete-Albacete et al. Journal of Cell Biology S1









nic) user on 29 June 2021
Figure S1. Internalization of Cav1 favors its entry into exosomes. (A) Colocalization analysis of Cav1 (red) and CD63 (green) in WT MEFs after 2-h
treatment with sodium orthovanadate (scale bar, 25 µm). Chart shows colocalization between CD63 and Cav1 as measured by Pearson’s correlation coefficient
(mean ± SD; n = 2, total 80 cells). (B) Colocalization analysis of Cav1 (red) and LBPA (green) after 10-min EDTA treatment (scale bar, 25 µm). Chart shows
Pearson’s correlation coefficient of the colocalization between the two labels (mean ± SD; n = 2, total 80 cells). (C) Confocal microscopy of Cav1 (red) and LBPA
(green) in PTRF-KD MEFs (scale bar, 25 µm). A representative Western blot of phosphorylated Cav1 is shown for PTRF-KD cells. Chart shows colocalization
analysis as measured by Pearson’s correlation coefficient (mean ± SD; n = 2, total 40 cells). (D) Confocal analysis of COS7 cells transfected with Rab5(Q79L)
(green) and the exosomal markers CD63 and Tsg101 (red; scale bar, 15 µm). Zoomed views show the intraluminal accumulation of both markers (scale bar,
5 µm). (E) Colocalization analysis of lysine-arginine Cav1 mutants (red) and CD63 (green; scale bar, 25 µm). Chart shows the percentage of labeled coloc-
alization (mean ± SD; n = 3). (F)Western blot analysis of Cav1 in cell lysates and released exosomes of control and PTRF-reconstituted PTRFKO cells. Tubulin
and Tsg101 were used as loading controls. Chart shows Cav1 levels in exosomes produced by either control or PTRF-reconstituted PTRFKO cells (mean ± SD;
n = 4). CNTRL, control; n.s., not significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure S2. Cav1-positive exosomes display a specific lipid/protein composition. (A)Western blot confirming Cav1KD in WT MEFs. Chart shows filipin III
mean fluorescence intensity at MVBs of WT MEFs transfected with either control (siCNTRL, silencing RNA duplex control) or Cav1-targeting siRNAs (siCav1,
siRNA duplex targeting Cav1; esiCav1, enzymatically prepared siRNAs targeting Cav1; mean ± SD; n = 4). (B) Distribution of LBPA (red) and filipin III (grey and
blue) in Rab5(Q79L)-expressing MEFs (green). Arrows indicate LBPA and filipin III colocalization at ILVs (scale bar, 5 µm). (C) Upper panel: lipids involved in
exosome biogenesis are summarized in the scheme (adapted from Subra et al., 2007). Lower panel: MS analysis of lipid composition profiles of Cav1KO MEF-
derived exosomes compared with WT-derived exosomes. Values denote relative content in Cav1KO-derived exosomes as normalized to the relative content
measured inWT exosomes for each lipid class (mean ± SD; n = 2 for determination of all lipid species except for cholesterol; for cholesterol determination, n = 3).
PA, phosphatidic acid; SM, sphingomyelin; PG, phosphatidylglycerol; PI, phosphatidylinositol; PC, phosphatidylcholine; PE, phosphatidylethanolamine.
(D) Enrichr diagram of “cellular component” category for proteins upregulated in either WTMEF–derived exosomes (top) or Cav1KOMEF–derived exosomes
(bottom). MCM complex, minichromosome maintenance protein complex. (E) Colocalization analysis of TnC (red) with CD63 or Cav1 (green) in U251 gli-
oblastoma cells expressing Rab5(Q79L) (white; scale bar, 25 µm; zoomed view scale bar, 2.5 µm). (F)Western blot analysis of TnC in cell lysates and released
exosomes of untreated or U18666A-treated WT MEFs. Tsg101 was used as exosome loading control. Chart shows the relative amount of TnC in exosomes
produced by WT control and U18666A-treated cells (mean ± SD; n = 4). (G) Western blot analysis confirming protein expression changes identified by
quantitative proteomics in WT fibroblast lysates and purified exosomes compared with Cav1KO counterparts. (H) Validation of lentivirus-mediated KD (scr,
scrambled control sequence; Cav1, Cav1-targeting shRNA) of Cav1 mRNA across tumor cell lines (T98: glioblastoma; B16F10: melanoma; MDAMB231: breast
cancer). (I) Western blot analysis of TnC secretion in exosomes produced by the different tumor cell lines described in H. Tsg101 and Alix were used as
exosomal markers. CNTRL, control. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure S3. Exosome inhibition favors intracellular TnC accumulation. (A) Western blot analysis (left) and quantification of exosome particle production
per cell (right graph) showing reduced exosome secretion by WT fibroblasts after treatment with dmA or GW4869 (mean ± SEM; n = 3). (B) Pipeline of the
fiberness macro (see Materials and methods). The original image, a, is first preprocessed (b), and nearly unidimensional tubular structures are enhanced to
obtain an image for fiberness scoring (c). M0measures the mean fiberness score in the whole image. a9 and c9 showmagnifications of indicated region (red box)
in panels a and c. (C) Representative Western blot and quantification (mean ± SEM; n = 9) showing the effect of indicated small-compound inhibitors on
intracellular TnC accumulation. (D) Assessment of ER stress in WT MEFs treated with exosome secretion inhibitors dmA and GW4689. Upper panel: agarose
gel for RT-PCR XBP1 mRNA splicing analysis. sXBP1, spliced mRNA species; uXBP1, unspliced mRNA species; Thapsig., Thapsigargin; Tunicam., Tunicamycin.
Lower panel: quantitative (q) RT-PCR assessment of CHOPmRNA expression across indicated treatments. (E) Confocal microscopy analysis of Golgi (in green)
labeled with GM130 in WT MEFs treated with exosome secretion inhibitors dmA and GW4689 (scale bar, 15 µm). (F and G) qRT-PCR assessment of KD
efficiency of indicated siRNA treatments in WT fibroblasts (F) and Western blot (G). (H) Representative Western blot and quantification (mean ± SEM; n = 9)
showing the effect of siRNA targeting Tsg101 and nSMase1 and 2 on intracellular TnC accumulation. (I) RepresentativeWestern blot of FN and pentraxin across
both lysates and purified exosomes from WT and Cav1KO fibroblasts. (J) Representative Z-stack projection confocal microscopy images showing the effect of
siRNAs targeting Tsg101 and nSMase1 and 2 on MEF FNmatrix deposition (green; scale bar, 50 µm; mean ± SEM; n = 5). (K) FN deposition of WTMEFs treated
with U18666A, as determined by Z-stack projection confocal microscopy (scale bar, 40 µm). Chart shows extracellular FN deposition in fibers produced by
either untreated or U18666A-treated WT MEFs, as measured using custom software (mean ± SD; n = 8). (L) Depiction of an MCS between the endosomal
compartment and the ER. Pairs of proteins described as key players for tethering and cholesterol transfer are indicated by dashed lines. Yellow arrows indicate
the direction of cholesterol transfer as regulated by each tethering complex. From the ER toward the endosomes (box I) or from the endosomes to the ER (box
II). n.s., not significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure S4. Exosomes derived from CAFs modulate ECM deposition. (A)Western blot analysis (left) and exosome particle production per cell (right) show
reduced exosome secretion by CAFs after treatment with dmA or GW4869 (mean ± SD; n = 3). (B and C) Representative Z-stack projection confocal mi-
croscopy images showing the effect of exosome inhibitor drugs (dmA and GW4689) on CAF TnC matrix deposition (B; scale bar, 20 µm; mean ± SEM; n = 5) and
CAF FN matrix deposition (C; mean ± SEM; n = 5; scale bar, 50 µm). (D) ER stress was assessed by analysis of XBP1 mRNA splicing in CAFs treated with
inhibitors of exosome biogenesis (dmA or GW4869). sXBP1, spliced mRNA species; uXBP1, unspliced mRNA species; Thapsig., Thapsigargin; Tunicam., Tu-
nicamycin. (E) Confocal microscopy assessment of ER (immunolabeled for calreticulin; left panels; scale bar, 5 µm) and Golgi subcellular distribution (im-
munolabeled for GM130; right panels; scale bar, 20 µm) in CAFs treated with either dmA or GW4869. (F) Confocal microscopy showing accumulation of TnC
(red; white arrows) within the ER (green) in chloroquine-treated Cav1KO MEFs (scale bar, 20 µm). Chart shows Pearson’s correlation coefficient for coloc-
alization between TnC and calreticulin in Cav1KO cells across indicated conditions (mean ± SD; n = 3). (G) Impact of exogenous supplementation of Alexa Fluor
647–LDLs (in green) on TnC distribution (in red) in WT MEFs overexpressing Rab5(Q79L) mutant (in grey). Scale bar, 20 µm. Zoomed views show intraluminal
accumulation of TnC upon treatment (scale bar, 5 µm). Histogram shows pixel intensities for Rab5(Q79L) (grey) and TnC (red) along the lines indicated on the
images. (H) Confocal microscopy analysis of Cav1 distribution in U18666A-treated WT fibroblasts (scale bar, 20 µm). Zoomed images (scale bar, 10 µm).
(I) Z-stack projection of confocal microscopy images show TnC (red) in matrices deposited by WT fibroblasts treated with LDLs (scale bar, 20 µm). CNTRL,
control; n.s., not significant. For all graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure S5. Disruption of ER-MVB contact sites modulates TnC matrix deposition. (A) Representative confocal microscopy of either WT or TnCKO CDMs
showing FN (green) and TnC (red; scale bar, 20 µm). (B) Phase-contrast microscopy showing morphological changes in MDA-MB468 cells 36 h after exposure
to MDA-MB231–derived exosomes (scale bar, 10 µm). (C) Top: Western blot analysis of Cav1KD efficiency in CCD-1069S CAFs. Middle: Z-stack projection of
confocal microscopy images showing TnC (red) in matrix deposited by CAFs stably expressing either scrambled shRNA (shScr) or Cav1-targeting shRNA
(shCav1; scale bar, 40 µm). Bottom: Phase-contrast microscopy showing morphological changes in MDA-MB468 cells 36 h after exposure to exosomes derived
from either shScr or shCav1 CAFs (scale bar, 10 µm). (D) Quantitative RT-PCR assessment of VAPA and ORP1L mRNA KD efficiency in Cav1KO fibroblasts.
(E) Top: Graphical scheme. Bottom: 3D reconstruction of TnC fibers deposited by exosomes produced by WTMEFs. (F)Wound closure assays performed with
MDA-MB468 cells treated with fibroblast-derivedWT and Cav1KO exosomes. The graph plots relative wound area (n = 6). (G)Number of invasive MDA-MB468
cells in transwell assays after exposure to exosomes derived from WT or Cav1KO fibroblasts (mean ± SD; n = 3). (H) Representative Western blot analysis of
WT and TnCKO MEF-derived exosomes. (I) Phase-contrast microscopy of MDA-MB468 migration in spheroids generated in the presence of either WT or
TnCKOMEF-derived exosomes over 72 h. Graph shows quantitative analysis of spheroidmigration (mean ± SEM; n = 11). (J) Immunofluorescencemicroscopy of
lung sections from TnCKO mice injected in the tail vein with WT or Cav1KO fibroblast-derived exosomes. Control mice were injected with PBS. Exosome foci
are green. White arrowheads indicate regions of TnC deposition (red). Immunofluorescence images are representative of seven random fields from two in-
dependent experiments. The charts show exosome foci accumulation in liver and in lungs after WT or Cav1KO exosome injection. CNTRL, control. For all
graphs, *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Data S1 and Data S2 are provided online as separate files. Data S1 presents high-throughput comparative proteomics of cell lysates
and exosomes derived from either WT or Cav1KO fibroblasts. Data S2 presents high-throughput comparative proteomics of
exosomes derived from MDAMB231 or MDAMB468 cells.
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